Simple Summary This review aims to shed light on the proliferative markers important in the
everyday clinical management of colorectal cancer (CRC), ranging from simple methods of …

Background Early rectal cancer (ERC) is adenocarcinoma that has invaded into, but not
extended beyond, the submucosa of the rectum (that is a T1 tumour). Local excision is …

Aims: To investigate dysregulation of the wnt signalling pathway by assessing β‐catenin
expression/increasing expression and loss of cytoplasmic adenomatous polyposis coli …

Background Epithelial-mesenchymal transition (EMT) plays a crucial role in the progression
and aggressiveness of colorectal carcinoma. E-cadherin is the best-characterized molecular …

Background L1, a new target gene for Wnt/β-catenin–TCF signaling, has been identified in
the invasive front of colorectal cancer cells in vitro study. The L1 molecule is localized on the …

Research towards biomarkers that predict patient outcome in colorectal cancer (CRC) is
rapidly expanding. However, none of these biomarkers have been recommended by the …

The aim of the present study was to investigate the localization and distribution of the
putative brain tumour stem cell marker CD133 in formalin fixed paraffin embedded …

E-cadherin and catenins play key roles in cell adhesion and motility. Little is known about
the changes in expression of these molecules in the progression of ovarian carcinomas. In …

Colorectal cancer is the third most common cancer type in the Western world. In search of
new treatment possibilities, the inflammation mediators, know as cysteinyl leukotrienes …

Background β-catenin plays a key role in the progression of colorectal cancer (CRC).
However, its prognostic significance for patients with CRC remains controversial …